Philadelphia Trust Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $893K | Sell |
37,095
-1,195
| -3% | -$31.3K | 0.06% | 127 |
|
|
2026
Q1 | $1.07M | Hold |
38,290
| – | – | 0.08% | 118 |
|
|
2025
Q4 | $953K | Sell |
38,290
-250
| -0.6% | -$6.3K | 0.07% | 121 |
|
|
2025
Q3 | $982K | Hold |
38,540
| – | – | 0.07% | 119 |
|
|
2025
Q2 | $934K | Hold |
38,540
| – | – | 0.07% | 118 |
|
|
2025
Q1 | $977K | Sell |
38,540
-42
| -0.1% | -$1.1K | 0.08% | 114 |
|
|
2024
Q4 | $1.02M | Hold |
38,582
| – | – | 0.08% | 117 |
|
|
2024
Q3 | $1.12M | Buy |
38,582
+16,550
| +75% | +$483K | 0.08% | 116 |
|
|
2024
Q2 | $616K | Hold |
22,032
| – | – | 0.05% | 137 |
|
|
2024
Q1 | $611K | Buy |
22,032
+501
| +2% | +$13.9K | 0.05% | 141 |
|
|
2023
Q4 | $620K | Sell |
21,531
-815
| -4% | -$24.6K | 0.06% | 136 |
|
|
2023
Q3 | $741K | Buy |
22,346
+2,080
| +10% | +$73.6K | 0.08% | 126 |
|
|
2023
Q2 | $743K | Sell |
20,266
-2,511
| -11% | -$97.7K | 0.07% | 132 |
|
|
2023
Q1 | $929K | Hold |
22,777
| – | – | 0.09% | 121 |
|
|
2022
Q4 | $1.17M | Hold |
22,777
| – | – | 0.13% | 108 |
|
|
2022
Q3 | $997K | Buy |
22,777
+1,940
| +9% | +$94.3K | 0.11% | 102 |
|
|
2022
Q2 | $1.09M | Sell |
20,837
-2,821
| -12% | -$144K | 0.11% | 105 |
|
|
2022
Q1 | $1.23M | Buy |
23,658
+95
| +0.4% | +$4.93K | 0.1% | 108 |
|
|
2021
Q4 | $1.39M | Buy |
23,563
+518
| +2% | +$25.7K | 0.1% | 106 |
|
|
2021
Q3 | $991K | Buy |
23,045
+967
| +4% | +$42.8K | 0.07% | 131 |
|
|
2021
Q2 | $865K | Sell |
22,078
-2,689
| -11% | -$105K | 0.06% | 143 |
|
|
2021
Q1 | $897K | Sell |
24,767
-16,155
| -39% | -$574K | 0.07% | 139 |
|
|
2020
Q4 | $1.51M | Sell |
40,922
-1,129
| -3% | -$41.4K | 0.12% | 104 |
|
|
2020
Q3 | $1.46M | Buy |
42,051
+1,697
| +4% | +$59.5K | 0.14% | 98 |
|
|
2020
Q2 | $1.25M | Sell |
40,354
-1,958
| -5% | -$66.5K | 0.13% | 90 |
|
|
2020
Q1 | $1.31M | Buy |
42,312
+475
| +1% | +$16.2K | 0.17% | 77 |
|
|
2019
Q4 | $1.55M | Sell |
41,837
-3,998
| -9% | -$142K | 0.13% | 97 |
|
|
2019
Q3 | $1.56M | Sell |
45,835
-896
| -2% | -$32.6K | 0.15% | 94 |
|
|
2019
Q2 | $1.92M | Sell |
46,731
-712
| -2% | -$28.3K | 0.17% | 92 |
|
|
2019
Q1 | $1.91M | Sell |
47,443
-2,582
| -5% | -$103K | 0.17% | 86 |
|
|
2018
Q4 | $2.07M | Sell |
50,025
-2,951
| -6% | -$123K | 0.22% | 75 |
|
|
2018
Q3 | $2.21M | Buy |
52,976
+1,449
| +3% | +$55.8K | 0.18% | 86 |
|
|
2018
Q2 | $1.77M | Sell |
51,527
-2,019
| -4% | -$69K | 0.16% | 89 |
|
|
2018
Q1 | $1.8M | Sell |
53,546
-448
| -0.8% | -$15.4K | 0.15% | 95 |
|
|
2017
Q4 | $1.85M | Buy |
53,994
+158
| +0.3% | +$5.39K | 0.15% | 98 |
|
|
2017
Q3 | $1.82M | Buy |
53,836
+3,642
| +7% | +$117K | 0.15% | 98 |
|
|
2017
Q2 | $1.6M | Hold |
50,194
| – | – | 0.14% | 102 |
|
|
2017
Q1 | $1.63M | Buy |
50,194
+5,382
| +12% | +$170K | 0.13% | 102 |
|
|
2016
Q4 | $1.38M | Buy |
44,812
+1,248
| +3% | +$38.1K | 0.11% | 109 |
|
|
2016
Q3 | $1.4M | Buy |
43,564
+1,175
| +3% | +$39.3K | 0.12% | 103 |
|
|
2016
Q2 | $1.42M | Buy |
42,389
+1,118
| +3% | +$35.7K | 0.12% | 100 |
|
|
2016
Q1 | $1.16M | Buy |
41,271
+2,050
| +5% | +$58.6K | 0.1% | 101 |
|
|
2015
Q4 | $1.22M | Buy |
39,221
+843
| +2% | +$26.5K | 0.1% | 101 |
|
|
2015
Q3 | $1.14M | Buy |
38,378
+37,141
| +3,003% | +$1.19M | 0.1% | 96 |
|
|
2015
Q2 | $35K | Sell |
1,237
-41,458
| -97% | -$1.35M | 0.13% | 97 |
|
|
2015
Q1 | $1.41M | Buy |
42,695
+726
| +2% | +$23.1K | 0.11% | 100 |
|
|
2014
Q4 | $1.24M | Buy |
41,969
+245
| +0.6% | +$7.03K | 0.1% | 92 |
|
|
2014
Q3 | $1.17M | Buy |
41,724
+422
| +1% | +$11.8K | 0.07% | 95 |
|
|
2014
Q2 | $1.16M | Sell |
41,302
-112
| -0.3% | -$3.19K | 0.07% | 95 |
|
|
2014
Q1 | $1.26M | Sell |
41,414
-854
| -2% | -$25.5K | 0.08% | 93 |
|
|
2013
Q4 | $1.23M | Buy |
42,268
+554
| +1% | +$16.1K | 0.08% | 104 |
|
|
2013
Q3 | $1.14M | Buy |
41,714
+374
| +0.9% | +$10.2K | 0.08% | 105 |
|
|
2013
Q2 | $1.1M | Buy |
+41,340
| New | +$1.14M | 0.08% | 105 |
|
Other funds holding PFE
Philadelphia Trust Company's PFE Position: Q2 2026 in Review
Philadelphia Trust Company reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $31.3K and leaving 37,095 shares worth $893K. The position accounts for 0.06% of the portfolio, ranked #127.
Philadelphia Trust Company first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.21M in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Philadelphia Trust Company held 37,095 shares of Pfizer worth $893K as of Q2 2026.
- Philadelphia Trust Company sold 1,195 Pfizer shares in Q2 2026, an estimated $31.3K.
- Pfizer made up 0.06% of Philadelphia Trust Company's portfolio in Q2 2026, its #127 holding.
- Philadelphia Trust Company first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Philadelphia Trust Company's Pfizer position peaked at $2.21M in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Philadelphia Trust Company's 13F filing for Q2 2026, filed 10 Aug 2026.